Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in NNVC — Nanoviricides, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to NNVC Full portfolio

Position in NNVC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$690
-$710 QoQ
Shares Held
500
-50.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 48 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NNVC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. NNVC ranks #369 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in NNVC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $690 500
2025-06-30 $1,400 1,000
2025-03-31 $1,170 1,000
2024-12-31 $1 1
2024-03-31 $155 135
2023-12-31 $1,154 1,133
2023-09-30 $1,510 1,128
2023-06-30 $1,344 1,170
2023-03-31 $1,313 1,123
2022-12-31 $1,244 1,122
2022-09-30 $1,937 1,120
2022-06-30 $3,984 2,120
2022-03-31 $10,598 5,071
2021-12-31 $18,875 5,074
2021-09-30 $23,542 5,074
2021-06-30 $23,500 5,065
2021-03-31 $23,920 5,068
2020-12-31 $14,536 5,065
2020-09-30 $19,449 5,065
2020-06-30 $30,211 4,039
2020-03-31 $23,200 4,042